Table 3

Thickness of each fundus layer in the peripapillary region for different degrees of myopic maculopathy

Thickness, μm0 (N=254)1 (N=239)2 (N=46)Total (N=539)P value
ChT-S152±43125±4683±34134±48<0.001 a, b, c
ChT-I112±3491±3263±2898±36<0.001 a, b, c
ChT-N148±44125±4190±39133±46<0.001 a, b, c
ChT-T127±4688±3159±37104±46<0.001 a, b, c
RT-S282±27279±22272±24280±250.021 b
RT-I260±22257±19257±24258±210.134
RT-N231±20226±18224±24228±200.003 a, b
RT-T281±18279±18279±23280±190.369
GCL+-S35±835±834±735±80.966
GCL+-I32±632±734±832±70.106
GCL+-N40±740±1143±840±90.123
GCL+-T52±947±943±1149±9<0.001 a, b, c
RNFLT-S110±22110±23103±23110±220.099
RNFLT-I99±1896±1793±1997±180.078
RNFLT-N53±1549±1646±1951±160.001 a, b
RNFLT-T87±1996±21102±2492±21<0.001 a, b
  • Statistical significance was tested using analysis of variance, and the Bonferroni method was used for post hoc tests. Statistical significance was defined as p<0.05 (two tailed).

  • Group 0—without myopic maculopathy; group 1—tessellated fundus; group 2—diffuse chorioretinal atrophy.

  • For post hoc tests, superscript a refers to significant difference between group 0 and group 1 (P<0.05), superscript b refers to significant difference between group 0 and group 2 (P<0.05), and superscript c refers to significant difference between group 1 and group 2 (P<0.05)

  • ChT, choroidal thickness; RT, retinal thickness; GCL+, combined thickness of the ganglion cell layer and the inner plexiform layer; RNFLT, retinal nerve fibre layer thickness; S, superior; I, inferior; N, nasal; T, temporal.;